Danaher Corporation
Sentinellis Health Score
6.3/10
$118.2B
$24.6B
32.4x
AI Summary
Danaher manufactures specialized equipment and supplies that pharmaceutical companies use to develop and produce drugs, particularly biologics like monoclonal antibodies. They also make diagnostic instruments for hospitals and research labs, along with software and consumables that support the entire drug development lifecycle. The company serves customers in over 60 countries through well-known brands like Beckman Coulter, Leica Microsystems, and Pall.
Danaher is a $118 billion healthcare and life sciences conglomerate that makes equipment, chemicals, and software used by pharmaceutical companies and hospitals [Yahoo Finance]. The company operates through three divisions: Biotechnology (equipment for drug manufacturing), Life Sciences (research instruments and genomics tools), and Diagnostics (hospital testing equipment) [Yahoo Finance]. Despite recent stock underperformance, its core bioprocessing business is recovering strongly with equipment orders up 30%+ as pharma companies expand production capacity [Yahoo Finance].
Solid cash generation with moderate leverage, though profitability metrics show room for improvement
Recent News
Strength in Danaher's Biotechnology Unit Seems Firm: More Upside Ahead?
Yahoo Finance· 2026-05-20Why The Narrative Around Danaher (DHR) Is Shifting With Bioprocess Recovery And Masimo Deal
Simply Wall St· 2026-05-20Genedata Introduces AI-Native CMC Platform to Accelerate Drug Development and Manufacturing
Yahoo Finance· 2026-05-19Life Science Instrumentation Market Forecast Report 2025-2031: Expanding Activities in Genomics, Proteomics, and Drug Discovery with Thermo Fisher Scientific, Danaher, Agilent, and Shimadzu Leading
Yahoo Finance· 2026-05-18Japan In Vitro Diagnostics Market Research Trends and Forecast Report 2026-2035 Featuring, Abbott Laboratories, Arkray, Danaher, Fujirebio, H.U., Roche Diagnostics, Sysmex, Tosoh
Yahoo Finance· 2026-05-18Solid Q1 and Guidance Underlines Why Danaher Corporation (DHR) is one of Steve Cohen’s Large-Cap Stock Picks
Yahoo Finance· 2026-05-17
Risk Analysis
Opportunities
Full Financials
Executive Team
Unlock the full Danaher Corporation analysis
Create a free account to access the complete AI-generated report with inline citations.
- Risks, opportunities, and red flags with sources
- 100+ financial metrics with charts and benchmarks
- Full news summaries with source links
- Executive team and compensation details
- PDF export for offline use
Other companies you might find interesting
Same sector (Healthcare) or comparable health.